H.R. 4402 · 118th Congress
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
- Stage
- In committee
- Sponsor
- Michael Burgess
- Introduced
- 2023-06-30
- Latest action
- 2024-12-17 · Referred to the Subcommittee on Health.
Summary
This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.